![The mechanisms of sorafenib resistance in hepatocellular carcinoma: theoretical basis and therapeutic aspects | Signal Transduction and Targeted Therapy The mechanisms of sorafenib resistance in hepatocellular carcinoma: theoretical basis and therapeutic aspects | Signal Transduction and Targeted Therapy](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41392-020-0187-x/MediaObjects/41392_2020_187_Fig5_HTML.png)
The mechanisms of sorafenib resistance in hepatocellular carcinoma: theoretical basis and therapeutic aspects | Signal Transduction and Targeted Therapy
![Mechanism of action of sorafenib. Sorafenib exerts a dual anticancer... | Download Scientific Diagram Mechanism of action of sorafenib. Sorafenib exerts a dual anticancer... | Download Scientific Diagram](https://www.researchgate.net/publication/26767509/figure/fig2/AS:202820637728778@1425367616886/Mechanism-of-action-of-sorafenib-Sorafenib-exerts-a-dual-anticancer-effect-on-the-tumor.png)
Mechanism of action of sorafenib. Sorafenib exerts a dual anticancer... | Download Scientific Diagram
![The mechanisms of sorafenib resistance in hepatocellular carcinoma: theoretical basis and therapeutic aspects | Signal Transduction and Targeted Therapy The mechanisms of sorafenib resistance in hepatocellular carcinoma: theoretical basis and therapeutic aspects | Signal Transduction and Targeted Therapy](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41392-020-0187-x/MediaObjects/41392_2020_187_Fig4_HTML.png)
The mechanisms of sorafenib resistance in hepatocellular carcinoma: theoretical basis and therapeutic aspects | Signal Transduction and Targeted Therapy
![Frontiers | Effect of the Hypoxia Inducible Factor on Sorafenib Resistance of Hepatocellular Carcinoma | Oncology Frontiers | Effect of the Hypoxia Inducible Factor on Sorafenib Resistance of Hepatocellular Carcinoma | Oncology](https://www.frontiersin.org/files/MyHome%20Article%20Library/641522/641522_Thumb_400.jpg)
Frontiers | Effect of the Hypoxia Inducible Factor on Sorafenib Resistance of Hepatocellular Carcinoma | Oncology
![Cancers | Free Full-Text | Sorafenib Resistance in Hepatocellular Carcinoma: The Relevance of Genetic Heterogeneity | HTML Cancers | Free Full-Text | Sorafenib Resistance in Hepatocellular Carcinoma: The Relevance of Genetic Heterogeneity | HTML](https://www.mdpi.com/cancers/cancers-12-01576/article_deploy/html/images/cancers-12-01576-g002.png)
Cancers | Free Full-Text | Sorafenib Resistance in Hepatocellular Carcinoma: The Relevance of Genetic Heterogeneity | HTML
![Mechanisms of Action of Drugs Effective in Hepatocellular Carcinoma - Sarcognato - 2019 - Clinical Liver Disease - Wiley Online Library Mechanisms of Action of Drugs Effective in Hepatocellular Carcinoma - Sarcognato - 2019 - Clinical Liver Disease - Wiley Online Library](https://aasldpubs.onlinelibrary.wiley.com/cms/asset/bf9e87e1-9c5a-40fc-ab0e-3bbd07d6a0de/cld810-fig-0001-m.jpg)
Mechanisms of Action of Drugs Effective in Hepatocellular Carcinoma - Sarcognato - 2019 - Clinical Liver Disease - Wiley Online Library
![Evolution in medicinal chemistry of sorafenib derivatives for hepatocellular carcinoma - ScienceDirect Evolution in medicinal chemistry of sorafenib derivatives for hepatocellular carcinoma - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0223523419305975-gr2.jpg)
Evolution in medicinal chemistry of sorafenib derivatives for hepatocellular carcinoma - ScienceDirect
![Supplemental Materials for Efficacy of annexin A3 blockade in sensitizing hepatocellular carcinoma to sorafenib and regorafenib - Journal of Hepatology Supplemental Materials for Efficacy of annexin A3 blockade in sensitizing hepatocellular carcinoma to sorafenib and regorafenib - Journal of Hepatology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/979dfd80-9dd2-4c84-9f24-a6627a1dc47b/fx1.jpg)
Supplemental Materials for Efficacy of annexin A3 blockade in sensitizing hepatocellular carcinoma to sorafenib and regorafenib - Journal of Hepatology
![Phloretin attenuates STAT-3 activity and overcomes sorafenib resistance targeting SHP-1–mediated inhibition of STAT3 and Akt/VEGFR2 pathway in hepatocellular carcinoma | Cell Communication and Signaling | Full Text Phloretin attenuates STAT-3 activity and overcomes sorafenib resistance targeting SHP-1–mediated inhibition of STAT3 and Akt/VEGFR2 pathway in hepatocellular carcinoma | Cell Communication and Signaling | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12964-019-0430-7/MediaObjects/12964_2019_430_Figa_HTML.png)
Phloretin attenuates STAT-3 activity and overcomes sorafenib resistance targeting SHP-1–mediated inhibition of STAT3 and Akt/VEGFR2 pathway in hepatocellular carcinoma | Cell Communication and Signaling | Full Text
![SOX9 enhances sorafenib resistance through upregulating ABCG2 expression in hepatocellular carcinoma - ScienceDirect SOX9 enhances sorafenib resistance through upregulating ABCG2 expression in hepatocellular carcinoma - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0753332220305072-ga1.jpg)
SOX9 enhances sorafenib resistance through upregulating ABCG2 expression in hepatocellular carcinoma - ScienceDirect
![Sorafenib mechanism of action: tumor proliferation and angiogenesis.... | Download Scientific Diagram Sorafenib mechanism of action: tumor proliferation and angiogenesis.... | Download Scientific Diagram](https://www.researchgate.net/publication/260429966/figure/fig2/AS:271829853052928@1441820695259/Sorafenib-mechanism-of-action-tumor-proliferation-and-angiogenesis-Adapted-from-Mol.png)
Sorafenib mechanism of action: tumor proliferation and angiogenesis.... | Download Scientific Diagram
![Current status of sorafenib nanoparticle delivery systems in the treatment of hepatocellular carcinoma Current status of sorafenib nanoparticle delivery systems in the treatment of hepatocellular carcinoma](https://www.thno.org/v11/p5464/thnov11p5464g001.jpg)
Current status of sorafenib nanoparticle delivery systems in the treatment of hepatocellular carcinoma
View of SUSTAINED RELEASE TABLETS OF SORAFENIB-SILIBININ COMBINATIONS FOR THE TREATMENT OF HEPATOCELLULAR CARCINOMA | International Journal of Applied Pharmaceutics
![Downregulation of signal transducer and activator of transcription 3 by sorafenib: A novel mechanism for hepatocellular carcinoma therapy Downregulation of signal transducer and activator of transcription 3 by sorafenib: A novel mechanism for hepatocellular carcinoma therapy](https://f6publishing.blob.core.windows.net/b82b12a8-8954-4c74-a1ce-33cc627db577/WJG-20-15269-g001.jpg)
Downregulation of signal transducer and activator of transcription 3 by sorafenib: A novel mechanism for hepatocellular carcinoma therapy
![Medicina | Free Full-Text | Predictive and Prognostic Factors in HCC Patients Treated with Sorafenib | HTML Medicina | Free Full-Text | Predictive and Prognostic Factors in HCC Patients Treated with Sorafenib | HTML](https://www.mdpi.com/medicina/medicina-55-00707/article_deploy/html/images/medicina-55-00707-g001.png)